Cambridge Index

		EXTRACORPOREAL SHOCKWAVE THERAPY (ESWT) Shockwave therapy is best known for its uses in the treatment of kidney stones, referred to as Extracorporeal Shockwave Lithotripsy (ESWL). Research has shown that shockwave therapy applied appropriately is also beneficial for the treatment of several orthopedic and podiatric conditions -- this procedure is called Extracorporeal Shockwave Therapy (ESWT). Shockwave therapy, or ESWT, is an FDA approved "non-invasive or no incision" treatment for both "plantar fasciitis, commonly associated with heel spurs" and "lateral epicondylitis, commonly referred to as tennis elbow." ESWT is also utilized to successfully treat Achilles tendons, knees, and shoulders. Shockwave therapy has a success rate of approximately 80%, which is comparable to its invasive counter parts. However, ESWT is preferrable in the long run due to the greatly reduced risk of scarring or infection. Additionally, it must be noted that the success rate for insertional Achilles tendonitis is well over 90%! Your physician offers ESWT. This non-invasive procedure is performed on an outpatient basis -- it does not require open surgery or a hospital stay. Patients may leave the treatment center shortly after the procedure is completed. In October 2000, the FDA granted clearance of ESWT for the treatment of plantar fasciitis and in July 2002, granted clearance for treatment of Epicondylitis. Additional treatment indications are currently being researched. Cambridge ESWT, LLC

EXTRACORPOREAL SHOCKWAVE THERAPY (ESWT)

Shockwave therapy is best known for its uses in the treatment of kidney stones, referred to as Extracorporeal Shockwave Lithotripsy (ESWL). Research has shown that shockwave therapy applied appropriately is also beneficial for the treatment of several orthopedic and podiatric conditions -- this procedure is called Extracorporeal Shockwave Therapy (ESWT).

Shockwave therapy, or ESWT, is an FDA approved "non-invasive or no incision" treatment for both "plantar fasciitis, commonly associated with heel spurs" and "lateral epicondylitis, commonly referred to as tennis elbow." ESWT is also utilized to successfully treat Achilles tendons, knees, and shoulders. Shockwave therapy has a success rate of approximately 80%, which is comparable to its invasive counter parts. However, ESWT is preferrable in the long run due to the greatly reduced risk of scarring or infection. Additionally, it must be noted that the success rate for insertional Achilles tendonitis is well over 90%!

Your physician offers ESWT. This non-invasive procedure is performed on an outpatient basis -- it does not require open surgery or a hospital stay. Patients may leave the treatment center shortly after the procedure is completed. In October 2000, the FDA granted clearance of ESWT for the treatment of plantar fasciitis and in July 2002, granted clearance for treatment of Epicondylitis. Additional treatment indications are currently being researched.

Cambridge ESWT, LLC